HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

ZACKS INVESTMENT MANAGEMENT's Holding History (CIK: 0001086483)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 26,431 Value ($000) $1,779 Avg Close $67.27 Range $61.23 - $76.30

Q3 2025

Shares 26,121 Value ($000) $1,916 Avg Close $66.43 Range $51.78 - $79.50

Q4 2021

Shares 37,027 Value ($000) $1,489 Avg Close $37.33 Range $31.79 - $41.20

Q3 2021

Shares 34,805 Value ($000) $1,416 Avg Close $41.81 Range $37.80 - $46.62

Q2 2021

Shares 31,503 Value ($000) $1,431 Avg Close $44.26 Range $38.65 - $51.57

Q1 2021

Shares 31,349 Value ($000) $1,307 Avg Close $45.65 Range $38.80 - $56.40

Q4 2020

Shares 30,821 Value ($000) $1,316 Avg Close $35.95 Range $25.70 - $44.53

Q3 2020

Shares 26,707 Value ($000) $702 Avg Close $27.85 Range $25.17 - $29.77

Q2 2020

Shares 26,974 Value ($000) $723 Avg Close $22.56 Range $15.89 - $27.22

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	26,431	$1,779	$67.27	$61.23 - $76.30
Q3 2025	26,121	$1,916	$66.43	$51.78 - $79.50
Q4 2021	37,027	$1,489	$37.33	$31.79 - $41.20
Q3 2021	34,805	$1,416	$41.81	$37.80 - $46.62
Q2 2021	31,503	$1,431	$44.26	$38.65 - $51.57
Q1 2021	31,349	$1,307	$45.65	$38.80 - $56.40
Q4 2020	30,821	$1,316	$35.95	$25.70 - $44.53
Q3 2020	26,707	$702	$27.85	$25.17 - $29.77
Q2 2020	26,974	$723	$22.56	$15.89 - $27.22